Weinhofer, Isabelle
Rommer, Paulus
Zierfuss, Bettina http://orcid.org/0000-0002-5357-2630
Altmann, Patrick
Foiani, Martha
Heslegrave, Amanda
Zetterberg, Henrik http://orcid.org/0000-0003-3930-4354
Gleiss, Andreas
Musolino, Patricia L.
Gong, Yi
Forss-Petter, Sonja
Berger, Thomas
Eichler, Florian
Aubourg, Patrick
Köhler, Wolfgang
Berger, Johannes http://orcid.org/0000-0003-0182-2658
Funding for this research was provided by:
Austrian Science Fund (KLI 837-B, T562-B13, DK W1205, P26112-B19)
Association Européenne contre les Leucodystrophies (2018-003I2, 2020-003C1A)
Article History
Received: 28 May 2020
Accepted: 19 February 2021
First Online: 22 March 2021
Competing interests
: H.Z. has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, and CogRx, has given lectures in symposia sponsored by Fujirebio, Alzecure, and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg (all unrelated to the submitted work). The remaining authors declare no competing interests.